SecBot SecBot

LKFT

Lakefront Biotherapeutics NV
Nasdaq· CIK 0001421876 Biotech & Drug Discovery
$31.68 +0.03 (+0.11%)
Oct 26 4:00 PM ET · prev $31.65
Market cap
$2.1B
Mid cap
Consensus
Hold
13% Buy or better · 16 analysts
Median target
🔒 Subscribers only
1 year
+2.0%
from $31.05 · Oct 27
30 days
+6.2%
from $29.84
52-week range
$26.08–34.64
−9% from high · low Aug 5
Avg volume 20D
271.7K
shares / day
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 6 neutral oldest → newest, height = score
Avg score ·High conf. 6/7
Strongest NEUTRAL Lakefront Biotherapeutics completed the sale of its preclinical CAR-T pipeline to Armed Cell Therapeutics…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 9 added (0 new), 8 trimmed or exited.

  • AnalystsMIXED

    2 of 16 rate it Buy or better.

  • EstimatesRISING

    Current-quarter EPS estimate −$1.310 → $0.230 over 90 days.

  • TrendUPTREND

    9% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCADD407,800$12.2M
MILLENNIUM MANAGEMENT LLCADD181,090$5.4M
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED151,886$4.6M
CITADEL ADVISORS LLCTRIM88,343$2.6M
MORGAN STANLEYADD37,682$1.1M
GROUP ONE TRADING LLCDOUBLED17,577$527.0K
HRT FINANCIAL LPTRIM17,328$519.0K
BANK OF AMERICA CORP /DE/TRIM7,529$225.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

16 analysts
Hold 13% rate it Buy or better
Strong Buy1Buy1Hold6Sell5Strong Sell3

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Sep 23, 2026RBC Capital
UPGRADE
UPGRADEOutperform
Aug 11, 2026Morgan Stanley
MAINTAIN
MAINTAINEqual-Weight
Aug 11, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform

Earnings setup

Estimates
$0.23
EPS estimate, this quarter
+118%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.23$0.23–$0.23+0.0%$41.2M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY-$1.06-$1.75–-$0.37+0.0%$84.6M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 15, 2026
Short interest
🔒 Fresh data, subscribers only
Aug 14, 2026
Short interest
Short Interest: LKFT up 18% to 3.0M shares
Settlement 2026-08-14 | Days to cover: 10.17 | ≈4.51% of shares outstanding (est.)

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 SEC
Lakefront Biotherapeutics completed its share repurchase program, buying back 107,804 shares for ~€2.85 million…
6-K — Impact 2/10
Oct 15, 2026 Short interest report
🔒 Fresh data, subscribers only
Oct 14, 2026 SEC
Lakefront Biotherapeutics completed the sale of its preclinical CAR-T pipeline to Armed Cell Therapeutics for an $8…
6-K — Impact 4/10
Oct 13, 2026 SEC
Lakefront Biotherapeutics disclosed the repurchase of 126,322 of its own ordinary shares between October 5 and October…
6-K — Impact 2/10
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
407,800 shares ($12.2M)
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — ADD
181,090 shares ($5.4M)

SecBot reports

11 filings · 0 bullish · 0 bearish · 1 mixed · 10 neutral
All LKFT filing & press-release reports (11)